Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Jazz Pharmaceuticals plc

NASDAQ: JAZZ · Life Sciences · 12 alerts · CIK 1232524

Share price
$239.77Close, Nov 16
Market cap
$15.4B
Shares outstanding
64.19MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Jazz Pharmaceuticals plc filings on SEC EDGAR ↗

9:07 AM ET 8-K
M&A Deal

Jazz Pharmaceuticals Signs $820M M&A Deal with Actio Biosciences, Inc.

Jazz Pharmaceuticals completed its acquisition of Actio Biosciences for $820 million upfront, making Actio a wholly-owned subsidiary. The deal adds ABS-1230, a clinical-stage precision therapy for KCNT1-related epilepsy, to Jazz's rare disease and epilepsy pipeline. As part of the transaction, Actio spun out its non-ABS-1230 programs into a new private entity in which Jazz retains a minority stake.

Value
$820M
Counterparty
Actio Biosciences, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.